Compliance Key to Managing Postherpetic Neuralgia
Treating this neuropathic pain condition can be complicated because of polypharmacy, drug dosing schedules, adverse events, drug-drug interactions, and patient comorbidities.
Postherpetic Neuralgia
POSTHERPETIC NEURALGIA
Feature Article
Latest
Effect of Low-Level Laser Therapy on Incidence of Postherpetic Neuralgia
Because the increased cytokine levels in the acute phase of herpes zoster are assumed to be a potential mechanism for inducing PHN, the early suppression of these cytokines by LLLT may help prevent the development of PHN.
Is Asthma Linked to Shingles Risk in Adults?
Odds of herpes zoster 70% higher among people with respiratory condition.
Herpes Zoster Vaccine Not Cost-Effective in Adults Aged 50 Years, Study Shows
At willingness-to-pay threshold of 100,000 per QALY, 3 probability of vaccine being cost-effective.
Pregabalin: An Overview
A new analysis pooled patient-level data from 31 randomized, placebo-controlled studies of pregabalin in peripheral NeP.
PHN Therapy Efficacious in Phase 3 Study
Pfizer announced results from a phase-3 study evaluating pregabalin controlled-release (CR) formulation in adult patients with postherpetic neuralgia (PHN).
PHN Study Confirms Importance of Vaccination
New research highlights the incidence of postherpetic neuralgia (PHN) and its significant burden of disease among elderly patients over time.
Want to read more?
Please login or register first to view this content.